OUTSOURCED PHARMA MARKET RESEARCH REPORTS
Industry Standard Research – ISR Reports – is a full-service pharmaceutical market research company operating exclusively in the life sciences industry and a sister company of Outsourced Pharma. Their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions. You’ll find links to their pharmaceutical market syndicated research reports below.
ISR's market research reports are produced using direct feedback from decision-makers, which enables ISR to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to their customers. Each report is available for to purchase online and you may also download free preview files. If you have any questions, please feel free to email info@ISRreports.com.
TRENDS AND MARKET OUTLOOK REPORTS
Oral Dosage Forms Market Overview and Outlook (3rd Edition)
This market research report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what our survey respondents—all oral dose outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2024. Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to...
Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook
This market research report provides an overview of the current market dynamics in the small molecule sterile injectable manufacturing space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2022.
Sterile Injectable Drug Product Manufacturing Market Outlook (3rd Ed.)
This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.
Pharmaceutical Excipient Market Overview and Outlook
This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.
Development vs Commercial Outsourced Manufacturing Practices: Biologics
This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.
Development vs. Commercial Outsourced Manufacturing Practices: Small Molecule
This report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.
Bioprocessing Market Trends and Outsourcing Dynamics: 2020-2025 (3rd Edition)
This market research report affords readers the opportunity to gain insight into the bioprocessing market and where it’s heading. This report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what our survey respondents predict the marketplace will look like in five years.
Clinical Manufacturing Market Dynamics and Service Provider Benchmarking
This report provides an overview of the current market dynamics in the clinical manufacturing space as well as an outlook of what our survey respondents predict the marketplace will look like in 2022.
Cell & Gene Therapies Market Outlook
Outsourcing decision-makers for cell or gene therapies at sponsor organizations give an overview of the current market dynamics in the cell & gene therapies contract manufacturing space and predictions through 2026.
CONTRACT MANUFACTURER QUALITY BENCHMARKING
Small Molecule API Contract Manufacturer Quality Benchmarking (6th Edition)
This report includes data on 358 service encounters from 123 respondents who have been involved in outsourced small molecule API projects in the past 18 months. It will help biopharma companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.
Biologic API Contract Manufacturer Quality Benchmarking (6th Edition)
This market research report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to biologic API projects.
Biologic Drug Product Contract Manufacturer Quality Benchmarking
This report gives an-depth look at a subset of respondents from small and emerging biopharma companies. It will help small and emerging biopharmaceutical companies make more informed CMO decisions, and will help CMOs optimize operational and marketing strategies.
Small Molecule Drug Product Contract Manufacturer Quality Benchmarking (4th Edition)
Data for this report comes from 123 respondents with 383 service encounters involved in outsourced drug product projects in the past 18 months.
DEPARTMENT MODELS AND STRUCTURES
Benchmarking the Pharma Industry’s Market Research Function
ISR conducted five in-depth interviews and 31 online surveys with experienced market researchers in the biopharmaceutical space to gain a better grasp on the market research function. Research subjects shared their insights on the types of research performed, how their market research function is structured, and outsourcing behavior.
Development And Commercial Manufacturing Outsourcing Models
This market research report explores how sponsor organizations use contract manufacturers to streamline costs, better manage capacity, access scientific expertise, improve efficiencies and decrease time to market.
The CMC Function: Best Practices and Optimization
ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.
Benchmarking The Pharma Industry’s Medical Science Liaison (MSL) Function
This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...
Old Dog, New Tricks: How The Pharma Industry Is Innovating With Existing Technologies
Innovation in clinical technologies sometimes comes in the shape of disruptive new technologies and, other times, as a series of incremental changes and improvements. New data is revealing positive changes, and existing tech solutions are now being used in new ways to facilitate remote engagement, analyze data, and conduct hybrid clinical trials.
Do Strategic Partnerships Meet Outsourcers Expectations?
ISR’s CDMO Outsourcing Models report dives into three approaches to contracting manufacturing work, the motivations behind them, and which methods earn the greatest satisfaction among users.
Outsourcer Engagement Preferences – No Love For Linkedin
Despite the pandemic shifting away from in-person interaction, the data shows it has not had lasting impact on the preference for face-to-face communication with outsourcers.
Is OSD Becoming More Complicated?
Are CDMOs evaluated on the same metrics for simple and complex oral dose manufacturing projects? Data from ISR’s new report provides insight on these questions and more.
Outsourcing Drivers For Small Molecule Manufacturing
ISR’s recent survey of small molecule outsourcers found that the majority of respondents outsource for one of two reasons: for all of their manufacturing needs, or to augment their internal manufacturing capacity.
ABOUT ISR VIDEO
ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive:
- Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
- Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries. We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
- Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.
For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.